Articles From: Amalgamated Gold and Silver Inc. Signs Memorandum of Understanding (MOU) to Amarin Receives FDA Notification That Action on ANCHOR sNDA Review Will be Delayed


2014/2/5
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G012129-001&sourceType=1 MIAMI, FL--(Marketwired - February 05, 2014) - Amalgamated Gold and Silver Inc. (AGS) (PINKSHEETS: BCHS) today announced it has signed a MOU to acquire the Huajara Polymetalic Processing Plant in Oruro, Bolivia.
Sign-up for Amalgamated Gold and Silver Inc. Signs Memorandum of Understanding (MOU) investment picks
2014/1/29
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G011849-001&sourceType=1 MIAMI, FL --(Marketwired - January 29, 2014) - Amalgamated Gold and Silver Inc. (AGS) (PINKSHEETS: BCHS) today announced it will retain Exploration Alliance SA ( http://www.explorationalliance.com/home.html ) to perform the NI 43-101 at the St.
Sign-up for Amalgamated Gold and Silver Inc. Will Employ the Service of Exploration Alliance SA investment picks
2013/10/3
Walgreens provides up to 3 million life-saving vaccines to children in developing countries DEERFIELD, Ill.
Sign-up for Amanda Peet, Actress and Ambassador of UN Foundation's Shot@Life Program, Receives Flu Shot in Walgreens NYC Flagship Store investment picks
2014/1/28
MOVE DESIGNED TO BRING GLOBAL PERSPECTIVE AND INNOVATION TO FAST-EVOLVING U.S. AND LATAM HEALTH MARKETS NEW YORK , Jan.
Sign-up for Amar Urhekar Named President Of McCann Health Americas investment picks
2014/3/12
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1097347&ProfileId=051205&sourceType=1 LONDON, UNITED KINGDOM --
Sign-up for AMARA MINING PLC ANNOUNCES PRELIMINARY ECONOMIC ASSESSMENT FOR YAOURE investment picks
2013/10/21
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1060830&ProfileId=051205&sourceType=1 LONDON, UNITED KINGDOM --
Sign-up for Amara Mining PLC: Application for Voluntary Delisting From TSX investment picks
2013/8/16
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1043638&ProfileId=051205&sourceType=1 LONDON --
Sign-up for Amara Mining plc: Filing of Technical Report Following Baomahun FS investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1049456&ProfileId=051205&sourceType=1 LONDON, UNITED KINGDOM --
Sign-up for Amara Mining PLC: H1/Q2 2013 RESULTS investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1049651&ProfileId=051205&sourceType=1 LONDON --
Sign-up for Amara Mining PLC: Holding(s) in Company investment picks
2014/1/14
Mountain View, CA, Jan.
Sign-up for Amaranth Medical Announces Investment from Boston Scientific investment picks
2013/10/11
By Michael Calia Amarin Corp.
Sign-up for Amarin ADRs Take a Hit After FDA Releases Report on Cholesterol Drug investment picks
By Everdeen Mason Amarin Corp.
Sign-up for Amarin Alleges Omthera Violated Patent with Epanova Drug investment picks
2014/3/31
BEDMINSTER, N.J., DUBLIN, Ireland, and MONTGOMERY, Ala., March 31, 2014 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN) and Kowa Pharmaceuticals America, Inc., two biopharmaceutical companies focused on the development and commercialization of therapeutics to improve cardiovascular health, today announced an agreement to co-promote Amarin's flagship product, Vascepa ® (icosapent ethyl) capsules, in the United States.
Sign-up for Amarin and Kowa Pharmaceuticals America, Inc. Announce U.S. Co-Promotion Agreement for Vascepa(R) (icosapent ethyl) Capsules investment picks
2013/9/9
BEDMINSTER, N.J., and DUBLIN, Sept.
Sign-up for Amarin Announces 30th Patent for Vascepa(R) investment picks
2013/7/12
BEDMINSTER, N.J. and DUBLIN, Ireland, July 12, 2013 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN) ("Amarin" or the "Company") today announced that it had completed its previously announced underwritten public offering of 21,700,000 American Depositary Shares ("ADSs"). The underwriters purchased the ADSs from Amarin at a price of $5.60 per ADS, resulting in net proceeds to Amarin of approximately $121.1 million, after deducting estimated offering expenses payable by Amarin.
Sign-up for Amarin Announces Completion of Offering of American Depositary Shares investment picks
2013/9/25
BEDMINSTER, N.J., and DUBLIN, Ireland, Sept.
Sign-up for Amarin Announces Enrollment of the REDUCE-IT Cardiovascular Outcomes Study Surpasses 6,000 Patients investment picks
BEDMINSTER, N.J. and DUBLIN, Ireland, Oct.
Sign-up for Amarin Announces FDA Advisory Committee Outcome for the Use of Vascepa in the Treatment of High Triglycerides With Mixed Dyslipidemia investment picks
2014/2/21
BEDMINSTER, N.J. and DUBLIN, Ireland, Feb.
Sign-up for Amarin Announces FDA Award of Three-Year Exclusivity for Vascepa(R) (icosapent ethyl) Capsules investment picks
2014/1/15
BEDMINSTER, N.J., and DUBLIN, Ireland, Jan.
Sign-up for Amarin Announces FDA Review Division Response on ANCHOR SPA Agreement Reinstatement Request Will Be Delayed investment picks
2014/1/21
Conference Call Set for 8:00 a.m. ET today BEDMINSTER, N.J., and DUBLIN, Ireland, Jan.
Sign-up for Amarin Announces FDA Review Division Response to ANCHOR SPA Agreement Reinstatement Request investment picks
BEDMINSTER, N.J., and DUBLIN, Ireland, Dec.
Sign-up for Amarin Announces Leadership Changes investment picks
BEDMINSTER, N.J. and DUBLIN, Ireland, Oct.
Sign-up for Amarin Announces Plans to Reduce Expenses by Decreasing Staff Following Recent FDA Advisory Committee Vote investment picks
2014/2/4
BEDMINSTER, N.J., and DUBLIN, Ireland, Feb.
Sign-up for Amarin Announces Promotion of Aaron Berg to Senior Vice President, Marketing and Sales investment picks
2013/8/26
BEDMINSTER, N.J. and DUBLIN, Ireland, Aug.
Sign-up for Amarin Announces Submission of Supplemental New Drug Application for Novasep as Fourth Vascepa(R) Active Pharmaceutical Ingredient Supplier investment picks
BEDMINSTER, N.J., and DUBLIN, Ireland, Oct.
Sign-up for Amarin Corporation (NASDAQ: AMRN) Stock Trading Halted Today; FDA Advisory Committee to Review sNDA for Vascepa(R) ANCHOR Indication investment picks
2013/10/14
Levi & Korsinsky is investigating the Board of Directors of Amarin Corporation plc (“Amarin” or the “Company”) (NasdaqGM: AMRN) for possible violations of federal securities laws.
Sign-up for AMARIN CORPORATION SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Claims on Behalf of Shareholders of Amarin Corporation investment picks
2013/10/16
Levi & Korsinsky is investigating the Board of Directors of Amarin Corporation plc (“Amarin” or the “Company”) (NasdaqGM:AMRN) for possible violations of federal securities laws.
Sign-up for AMARIN CORPORATION SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Claims on Behalf of Shareholders of Amarin Corporation in Connection with FDA Release investment picks
BEDMINSTER, N.J. and DUBLIN, Ireland, Oct.
Sign-up for Amarin Informed by FDA That October 16th Advisory Committee Meeting Will Take Place as Scheduled investment picks
2013/12/20
BEDMINSTER, N.J. and DUBLIN, Ireland, Dec.
Sign-up for Amarin Receives FDA Notification That Action on ANCHOR sNDA Review Will be Delayed investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Amalgamated Gold and Silver Inc. Signs Memorandum of Understanding (MOU) to Amarin Receives FDA Notification That Action on ANCHOR sNDA Review Will be Delayed
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity